Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-29

Clinical Trial Update: Study of PXL01 Versus Placebo to Inhibit Adhesion Formation After Flexor Tendon Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial comparing PXL01 to placebo for inhibiting adhesion formation after flexor tendon surgery; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PXL01

Snippet

Sponsor: Pergamum AB | Conditions: Surgical Adhesions | Phase 2 | Status: COMPLETED | Results posted: 2014-05-29